ID   MCF-7/HER2-18
AC   CVCL_0U80
SY   MCF-7 HER2-18; MCF-7/Her2-18; MCF7/HER2-clone 18; MCF7/HER2-18; MCF/HER2-18
DR   BioSample; SAMN03471643
DR   cancercelllines; CVCL_0U80
DR   Wikidata; Q54904368
RX   PubMed=8095168;
RX   PubMed=25877200;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Transfected with: HGNC; 3430; ERBB2.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 14
//
RX   PubMed=8095168; DOI=10.1007/BF01961241;
RA   Benz C.C., Scott G.K., Sarup J.C., Johnson R.M., Tripathy D.,
RA   Coronado E., Shepard H.M., Osborne C.K.;
RT   "Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7
RT   cells transfected with HER2/neu.";
RL   Breast Cancer Res. Treat. 24:85-95(1992).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//